[Use these links to rapidly review the document The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement is not an offer to sell the securities and is not soliciting offers to buy the securities in any jurisdiction where the ]
[FOR RELEASE June 29, 2020 China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction BEIJING, China – June 29, 2020 – China Biologic will continue to take all necessary measures and actions to protect its rights and recoup all potential losses due to Xinjiang Deyuan]
[INDEX TO UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Page Unaudited Interim Condensed Consolidated Balance Sheets as of December 31, 2019 and March 31, 2020 F-2 Unaudited Interim Condensed Consolidated Statements of Comprehensive Income for the Three Months ended March 31, 2019 and]
[中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED ( A join t stoc k limite d compan y incorporate d i n th e People s Republi c o f Chin a wit h limite d liability) (Stock Code: 2628) ANNOUNCEMENT RESOLUTIONS PASSED AT THE ANNUAL GENERAL MEETING AND DISTRIBUTION OF FINAL DIVIDEND Board Board of Dir]
[] [(RULE 13a-14(a) or 15d-14(a) OF THE EXCHANGE ACT) I, Guohua Ku, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Recycling Energy Corporation; 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a ma]
[] [(RULE 13a-14(a) or 15d-14(a) OF THE EXCHANGE ACT) I, Guohua Ku, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Recycling Energy Corporation; 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a ma]
[Use these links to rapidly review the document The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement is not an offer to sell the securities and is not soliciting offers to buy the securities in any jurisdiction where the ]
[Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2020 Added 18,488 New Subscribers in 4Q20 4Q20 Revenues Increased by 19.2% YoY to RMB299.9 Million ($42.4 Million) 4Q20 Operating Income Increased by 68.1% YoY to RMB149.3 Million ($21.1 Million) N]
[中國人壽保險股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED ( A join t stoc k limite d compan y incorporate d i n th e People s Republi c o f Chin a wit h limite d liability) (Stock Code: 2628) ANNOUNCEMENT RESOLUTIONS PASSED AT THE ANNUAL GENERAL MEETING AND DISTRIBUTION OF FINAL DIVIDEND Board Board of Dir]
